Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinapril for Endothelial Function in Postmenopausal Hypertension
NCT00147524Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quinapril in hypertension (HTN), sponsored by Pfizer. Primary endpoint: Flow Mediated Dilatation at 24 weeks. Started Oct 2003; status: completed.
02
Drugs
quinapril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00147524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147524.